India continues rise as a global drug power

Once notorious for cheap knockoffs, India is assuming a mainstream role in the global drug industry thanks to stronger patent protections and cost pressures on name-brand drug makers in the West.  "Manufacturing, packaging and formulation are moving to India," says an industry consultant, who arranges tours of Indian factories for Western pharma execs thinking of outsourcing. Article


Suggested Articles

Teva will produce its new migraine drug at a plant in Israel and more news of note.

The shortage of childhood cancer drug vincristine was front and center during the Senate hearing for Stephen Hahn, nominee for FDA commissioner.

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.